+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dry Eye Syndrome Market - Global Forecast to 2030- Product Image
Dry Eye Syndrome Market - Global Forecast to 2030- Product Image
Sale

Dry Eye Syndrome Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896652
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dry Eye Syndrome Market grew from USD 4.71 billion in 2024 to USD 5.06 billion in 2025. It is expected to continue growing at a CAGR of 7.24%, reaching USD 7.16 billion by 2030.

Dry Eye Syndrome has emerged as a critical ophthalmic condition impacting millions of individuals worldwide, characterized by insufficient tear production and impaired tear film stability. As modern lifestyles intensify screen exposure and environmental factors such as air pollution and indoor climate control become ubiquitous, the prevalence of ocular surface disease continues to rise. Clinicians and industry leaders are now focusing on innovative therapeutic regimens and advanced diagnostic tools to address inflammation, lubrication, and meibomian gland dysfunction. This executive summary distills the most pertinent developments shaping treatment modalities, patient demographics, and market dynamics, equipping decision-makers with actionable insights. By examining technological breakthroughs, regulatory shifts, and key stakeholder strategies, we illuminate the pathways that will define the future of dry eye management and underscore the importance of strategic alignment across research, manufacturing, and distribution channels.

Transformative Shifts Impacting Treatment and Diagnosis

Over the past decade, transformative shifts have redefined dry eye treatment paradigms. The rise of minimally invasive procedures, such as lipiflow thermal pulsation and intense pulsed light therapy, has complemented traditional pharmacological approaches. Concurrently, digital health platforms and tele-ophthalmology solutions have accelerated diagnosis and patient monitoring, enabling real-time assessment of tear film metrics and gland morphology. Personalized medicine is gaining traction through meibography-guided interventions, harnessing imaging data to tailor treatment intensity. In parallel, formulation science has advanced preservative-free emulsions and hybrid drug-device combinations, enhancing ocular tolerance and therapeutic efficacy.

These innovations converge with an aging global population and escalating screen time among younger cohorts, driving demand for both acute symptom relief and long-term disease modification. Moreover, collaborations between device manufacturers and pharmaceutical developers are fostering integrated care models, while regulatory bodies worldwide adapt guidelines to accommodate novel therapies. Together, these shifts underscore a landscape in which multidisciplinary solutions and patient-centric delivery will dictate market leadership.

Evaluating the 2025 United States Tariff Impact

Looking ahead to 2025, the implementation of new United States tariffs on pharmaceutical imports and medical devices introduces a critical inflection point. Increased duties on active ingredients such as hyaluronic acid, cellulose derivatives, and advanced emulsifiers will elevate production costs for artificial tears and anti-inflammatory formulations. Simultaneously, tariffs on diagnostic equipment essential for meibography and therapeutic devices, including punctal plugs and ocular inserts, may disrupt established supply chains.

As manufacturers reassess sourcing strategies, many will pivot toward domestic production of key components to mitigate margin compression. Distributors may renegotiate pricing agreements or seek alternative suppliers abroad, potentially delaying product launches and limiting inventory availability. Healthcare providers could face higher reimbursement challenges, spurring demand for cost-effective generics and over-the-counter alternatives. In this shifting regulatory environment, agile supply-chain management and proactive engagement with policymakers will be vital to sustaining market access and preserving competitive advantage.

Key Segmentation Insights Across Multiple Dimensions

A granular segmentation analysis reveals divergent trajectories across treatment modalities and patient cohorts. In the realm of product type, anti-inflammatory drugs encompass calcineurin inhibitors, non-steroidal anti-inflammatory drugs, and steroids, each addressing distinct inflammatory pathways, while artificial tears extend from multi-use preservative-based formats to single-use preservative-free vials. Emulsions have bifurcated into aqueous and lipid formulations, optimizing tear-film stability, and medical devices range from sustained-release ocular inserts to punctal plugs that enhance tear retention. Age-group stratification identifies middle-age and young adults as heavy screen-use sufferers, centenarians and young seniors grappling with age-related lacrimal decline, and neonatal through adolescent populations presenting unique anatomical and compliance considerations.

Formulation type spans gels, liquid drops, ointments, and sprays, each balancing viscosity and ocular residence time, while distribution channels include eye care clinics, hospitals, online pharmacies, and retail outlets, reflecting evolving patient preferences for convenience and clinical oversight. Disease severity segments address mild, moderate, and severe presentations, guiding therapy intensity, and end-user distinctions between clinics, homecare settings, and hospital environments influence product design and packaging. Prescription type bifurcates into over-the-counter and prescription-only therapies, and base ingredients such as glycerin, hyaluronic acid, and mineral oils form the foundation of lubricating solutions. Finally, technology-driven approaches utilizing intense pulsed light therapy, lipiflow thermal pulsation, and meibography are converging to deliver diagnostic precision and targeted treatment efficacy.

Key Regional Insights Shaping Market Strategies

Regional dynamics underscore the heterogeneity of dry eye management worldwide. In the Americas, robust reimbursement frameworks and early adoption of device-based therapies drive sustained growth, with the United States leading in meibography utilization and Canada expanding tele-ophthalmology networks. Europe, the Middle East, and Africa exhibit diverse regulatory landscapes: Western Europe’s harmonized directives facilitate rapid product approvals, while emerging markets in the Middle East and Africa demand cost-sensitive solutions and localized manufacturing partnerships. Asia-Pacific stands out for its large patient base affected by high humidity fluctuations and industrial pollution, prompting aggressive expansion by domestic and multinational players alike. China and India are investing heavily in homecare devices and preservative-free formulations, whereas Japan and Australia prioritize stringent safety standards and advanced diagnostic infrastructures. Collectively, these regional insights highlight the need for tailored market entry strategies and adaptive pricing models to capture growth opportunities across varied healthcare ecosystems.

Competitive Landscape and Company Innovations

Leading companies are adopting distinct paths to differentiation and market share expansion. AbbVie Inc. leverages its global footprint to integrate anti-inflammatory biologics with emerging drug-device combinations, while AFT Pharmaceuticals focuses on nanotechnology-enhanced artificial tears for rapid relief. Akorn Operating Company and Alcon Vision deploy extensive distribution networks to promote preservative-free emulsions, and Bausch & Lomb pioneers advanced punctal plug designs. Global pharmaceutical giants such as GlaxoSmithKline and Novartis collaborate with academic centers on novel drug delivery platforms, whereas Johnson & Johnson emphasizes patient engagement through digital adherence programs. Mitotech S.A. and Nicox S.A. explore mitochondrial and nitric oxide pathways to address underlying ocular surface inflammation, and Otsuka Holdings applies neuroprotective research to ocular health.

Prestige Consumer Healthcare capitalizes on its OTC expertise, Sentiss Pharma focuses on affordability in emerging markets, and Sun Pharmaceutical Industries emphasizes vertically integrated manufacturing to enhance cost efficiency. Santen Pharmaceutical drives regional innovation in Asia and Europe, drawing on specialized ophthalmology research. These strategic initiatives underscore a balance between product innovation, geographic diversification, and partnership ecosystems to sustain competitive advantage.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize a multifaceted approach. First, expanding preservative-free and hybrid formulations will address rising patient demand for tolerable, long-acting therapies. Second, investing in in-office diagnostic technologies such as meibography and lipiflow units can differentiate service offerings and support evidence-based care. Third, fortifying supply chains through regional manufacturing hubs will mitigate tariff-related uncertainties and ensure continuous product availability. Fourth, forming alliances with digital health providers will enable remote monitoring and patient adherence programs, improving clinical outcomes and retention.

Moreover, segment-specific marketing strategies tailored to middle-age adults versus geriatric populations will enhance penetration, while targeted distribution through online pharmacies can capture tech-savvy consumers. Collaborating with payers to establish value-based reimbursement models will further incentivize adoption of higher-cost devices and combination therapies. Finally, continuous investment in R&D pipelines focused on novel anti-inflammatory targets and mitochondrial modulators will position organizations at the forefront of future treatment breakthroughs.

Conclusion and Strategic Imperatives

In summary, the dry eye syndrome market is undergoing rapid transformation driven by demographic shifts, technological advancements, and evolving regulatory environments. Tariff changes in 2025 will compel stakeholders to innovate supply-chain strategies and alternative sourcing, while segmentation analysis highlights nuanced patient and product dimensions that must inform targeted approaches. Regional disparities demand customized entry and pricing tactics, and company strategies reveal a dual emphasis on novel therapies and digital integration. Moving forward, success will hinge on the alignment of clinical insights, manufacturing agility, and strategic partnerships to meet diverse patient needs and capture emergent growth opportunities.

Market Segmentation & Coverage

This research report categorizes the Dry Eye Syndrome Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Anti-Inflammatory Drugs
    • Calcineurin Inhibitors
    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Steroids
  • Artificial Tears
    • Multi-Use
    • Preservative-Free
    • Preserved
    • Single-Use
  • Emulsions
    • Aqueous Emulsions
    • Lipid Emulsions
  • Medical Devices
    • Ocular Inserts
    • Punctal Plugs
  • Adults
    • Middle Age Adults
    • Young Adults
  • Geriatric
    • Centenarians
    • Young Seniors
  • Pediatrics
    • Adolescent
    • Neonatal
    • Toddler
  • Gels
  • Liquid Drops
  • Ointments
  • Sprays
  • Eye Care Clinics
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • Mild Dry Eye
  • Moderate Dry Eye
  • Severe Dry Eye
  • Clinics
  • Homecare Settings
  • Hospitals
  • Over the Counter (OTC)
  • Prescription Drugs
  • Cellulose Derivatives
  • Glycerin
  • Hyaluronic Acid
  • Mineral Oils
  • Intense Pulsed Light Therapy
  • Lipiflow Thermal Pulsation
  • Meibography

This research report categorizes the Dry Eye Syndrome Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Dry Eye Syndrome Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • AFT Pharmaceuticals
  • Akorn Operating Company LLC
  • Alcon Vision LLC
  • Bausch & Lomb Pvt Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Mitotech S.A.
  • Nicox S.A.
  • Novartis AG
  • Otsuka Holdings Co
  • Prestige Consumer Healthcare
  • Santen Pharmaceutical Co.ltd
  • Sentiss Pharma Pvt. Ltd
  • Sun Pharmaceutical Industries Ltd

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dry Eye Syndrome Market, by Product Type
8.1. Introduction
8.2. Anti-Inflammatory Drugs
8.2.1. Calcineurin Inhibitors
8.2.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
8.2.3. Steroids
8.3. Artificial Tears
8.3.1. Multi-Use
8.3.2. Preservative-Free
8.3.3. Preserved
8.3.4. Single-Use
8.4. Emulsions
8.4.1. Aqueous Emulsions
8.4.2. Lipid Emulsions
8.5. Medical Devices
8.5.1. Ocular Inserts
8.5.2. Punctal Plugs
9. Dry Eye Syndrome Market, by Age Group
9.1. Introduction
9.2. Adults
9.2.1. Middle Age Adults
9.2.2. Young Adults
9.3. Geriatric
9.3.1. Centenarians
9.3.2. Young Seniors
9.4. Pediatrics
9.4.1. Adolescent
9.4.2. Neonatal
9.4.3. Toddler
10. Dry Eye Syndrome Market, by Formulation Type
10.1. Introduction
10.2. Gels
10.3. Liquid Drops
10.4. Ointments
10.5. Sprays
11. Dry Eye Syndrome Market, by Distribution Channel
11.1. Introduction
11.2. Eye Care Clinics
11.3. Hospitals
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Dry Eye Syndrome Market, by Disease Severity
12.1. Introduction
12.2. Mild Dry Eye
12.3. Moderate Dry Eye
12.4. Severe Dry Eye
13. Dry Eye Syndrome Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Homecare Settings
13.4. Hospitals
14. Dry Eye Syndrome Market, by Prescription Type
14.1. Introduction
14.2. Over the Counter (OTC)
14.3. Prescription Drugs
15. Dry Eye Syndrome Market, by Base Ingredients
15.1. Introduction
15.2. Cellulose Derivatives
15.3. Glycerin
15.4. Hyaluronic Acid
15.5. Mineral Oils
16. Dry Eye Syndrome Market, by Technology
16.1. Introduction
16.2. Intense Pulsed Light Therapy
16.3. Lipiflow Thermal Pulsation
16.4. Meibography
17. Americas Dry Eye Syndrome Market
17.1. Introduction
17.2. Argentina
17.3. Brazil
17.4. Canada
17.5. Mexico
17.6. United States
18. Asia-Pacific Dry Eye Syndrome Market
18.1. Introduction
18.2. Australia
18.3. China
18.4. India
18.5. Indonesia
18.6. Japan
18.7. Malaysia
18.8. Philippines
18.9. Singapore
18.10. South Korea
18.11. Taiwan
18.12. Thailand
18.13. Vietnam
19. Europe, Middle East & Africa Dry Eye Syndrome Market
19.1. Introduction
19.2. Denmark
19.3. Egypt
19.4. Finland
19.5. France
19.6. Germany
19.7. Israel
19.8. Italy
19.9. Netherlands
19.10. Nigeria
19.11. Norway
19.12. Poland
19.13. Qatar
19.14. Russia
19.15. Saudi Arabia
19.16. South Africa
19.17. Spain
19.18. Sweden
19.19. Switzerland
19.20. Turkey
19.21. United Arab Emirates
19.22. United Kingdom
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. AbbVie Inc.
20.3.2. AFT Pharmaceuticals
20.3.3. Akorn Operating Company LLC
20.3.4. Alcon Vision LLC
20.3.5. Bausch & Lomb Pvt Ltd.
20.3.6. GlaxoSmithKline PLC
20.3.7. Johnson & Johnson Services, Inc.
20.3.8. Mitotech S.A.
20.3.9. Nicox S.A.
20.3.10. Novartis AG
20.3.11. Otsuka Holdings Co
20.3.12. Prestige Consumer Healthcare
20.3.13. Santen Pharmaceutical Co.ltd
20.3.14. Sentiss Pharma Pvt. Ltd
20.3.15. Sun Pharmaceutical Industries Ltd
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. DRY EYE SYNDROME MARKET MULTI-CURRENCY
FIGURE 2. DRY EYE SYNDROME MARKET MULTI-LANGUAGE
FIGURE 3. DRY EYE SYNDROME MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 28. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 34. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRY EYE SYNDROME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MULTI-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRESERVATIVE-FREE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRESERVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY AQUEOUS EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIPID EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY OCULAR INSERTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PUNCTAL PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MIDDLE AGE ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY CENTENARIANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY YOUNG SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY NEONATAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY TODDLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIQUID DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY EYE CARE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MILD DRY EYE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MODERATE DRY EYE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY SEVERE DRY EYE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY OVER THE COUNTER (OTC), BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MINERAL OILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY INTENSE PULSED LIGHT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIPIFLOW THERMAL PULSATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY MEIBOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. CANADA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 121. CANADA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 122. CANADA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 123. CANADA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 124. CANADA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. CANADA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 126. CANADA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 127. CANADA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 128. CANADA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 129. CANADA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. CANADA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 131. CANADA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 133. CANADA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 134. CANADA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. MEXICO DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 143. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. MEXICO DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 147. MEXICO DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 149. MEXICO DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. CHINA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 203. CHINA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 204. CHINA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 205. CHINA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 206. CHINA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. CHINA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 208. CHINA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 209. CHINA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 210. CHINA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 211. CHINA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. CHINA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 213. CHINA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 215. CHINA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 216. CHINA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. INDIA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. INDIA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 220. INDIA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 221. INDIA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 222. INDIA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 223. INDIA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 224. INDIA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 225. INDIA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 226. INDIA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 227. INDIA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. INDIA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 229. INDIA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 231. INDIA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 232. INDIA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. JAPAN DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 251. JAPAN DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 252. JAPAN DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 253. JAPAN DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 254. JAPAN DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 255. JAPAN DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 256. JAPAN DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 257. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 258. JAPAN DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 259. JAPAN DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. JAPAN DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 261. JAPAN DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 263. JAPAN DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 264. JAPAN DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 275. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 277. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 279. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 280. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 299. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 300. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 322. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 323. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 325. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 327. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 328. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 329. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 331. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 332. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 333. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 334. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 335. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 336. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 337. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 338. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 339. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 340. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY DISEASE SEVERITY, 2018-2030 (USD MILLION)
TABLE 341. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2030 (USD MILLION)
TABLE 343. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY BASE INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 344. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 345. THAILAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 346. THAILAND DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 347. THAILAND DRY EYE SYNDROME MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2030 (USD MILLION)
TABLE 348. THAILAND DRY EYE SYNDROME MARKET SIZE, BY EMULSIONS, 2018-2030 (USD MILLION)
TABLE 349. THAILAND DRY EYE SYNDROME MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 350. THAILAND DRY EYE SYNDROME MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 351. THAILAND DRY EYE SYNDROME MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 352. THAILAND DRY EYE SYNDROME MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 353. THAILAND DRY EYE SYNDROME MARKET SIZE, BY PEDI

Companies Mentioned

  • AbbVie Inc.
  • AFT Pharmaceuticals
  • Akorn Operating Company LLC
  • Alcon Vision LLC
  • Bausch & Lomb Pvt Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Mitotech S.A.
  • Nicox S.A.
  • Novartis AG
  • Otsuka Holdings Co
  • Prestige Consumer Healthcare
  • Santen Pharmaceutical Co.ltd
  • Sentiss Pharma Pvt. Ltd
  • Sun Pharmaceutical Industries Ltd

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type, By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type, By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Dry Eye Syndrome Market Size, Share, Trends, and Forecast by Disease Type, Drug Type, Product, Distribution Channel, and Region, 2025-2033 - Product Image

Dry Eye Syndrome Market Size, Share, Trends, and Forecast by Disease Type, Drug Type, Product, Distribution Channel, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Dry Eye Syndrome Market Report 2025 - Product Image

Dry Eye Syndrome Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Dry Eye Syndrome Drugs Market 2024-2028 - Product Image

Dry Eye Syndrome Drugs Market 2024-2028

  • Report
  • 168 Pages
  • Global
From
Dry Eye Medication Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Dry Eye Medication Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Dry Eye Drug Market

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators. Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.